Strategy for First-in-Human Studies (1/2) – MedTech CRO: Strategy Development Series скачать в хорошем качестве

Strategy for First-in-Human Studies (1/2) – MedTech CRO: Strategy Development Series

This video is part of our educational video series on clinical trials. Clips will cover three key areas: clinical trial strategy, clinical trial execution, and regulatory expertise in clinical trials. Please ⁠reach out to RQM+⁠ if you need support with clinical trials. ❓ What are the objectives and benefits of conducting 𝗳𝗶𝗿𝘀𝘁-𝗶𝗻-𝗵𝘂𝗺𝗮𝗻 𝘀𝘁𝘂𝗱𝗶𝗲𝘀? What are the key considerations and best practices for manufacturers? We have answers. 🏥 Here's the first video in our 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗖𝗥𝗢: 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗦𝗲𝗿𝗶𝗲𝘀 – 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 𝗳𝗼𝗿 𝗙𝗶𝗿𝘀𝘁-𝗶𝗻-𝗛𝘂𝗺𝗮𝗻 𝗦𝘁𝘂𝗱𝗶𝗲𝘀 (𝟭/𝟮). Join VP of Strategic Regulatory Affairs ⁠Sew-Wah Tay⁠ and VP of Global Regulatory Affairs ⁠Jaishankar Kutty, Ph.D.⁠ as they discuss crucial strategic considerations for first-in-human (FIH) studies. 𝗪𝗮𝘁𝗰𝗵 𝗮𝗻𝗱 𝘆𝗼𝘂 𝘄𝗶𝗹𝗹 𝗹𝗲𝗮𝗿𝗻: 📎 The objectives and benefits of conducting FIH studies 📎 Key considerations and best practices for manufacturers 📎 How to navigate early-stage challenges effectively Don't miss this strategic guidance that will help you streamline your FIH study process and make informed decisions. Watch now... and stay tuned for part two!